117 related articles for article (PubMed ID: 29272786)
1. Autophagy enhanced antitumor effect in K562 and K562/ADM cells using realgar transforming solution.
Wang X; Chen B; Zhao L; Zhi D; Hai Y; Song P; Li Y; Xie Q; Inam U; Wu Z; Yu L; Li H
Biomed Pharmacother; 2018 Feb; 98():252-264. PubMed ID: 29272786
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.
Shi D; Liu Y; Xi R; Zou W; Wu L; Zhang Z; Liu Z; Qu C; Xu B; Wang X
Int J Nanomedicine; 2016; 11():5823-5835. PubMed ID: 27853367
[TBL] [Abstract][Full Text] [Related]
4. Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.
Pastorek M; Gronesova P; Cholujova D; Hunakova L; Bujnakova Z; Balaz P; Duraj J; Lee TC; Sedlak J
Neoplasma; 2014; 61(6):700-9. PubMed ID: 25150315
[TBL] [Abstract][Full Text] [Related]
5. Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL.
Wang T; Wen T; Li H; Han B; Hao S; Wang C; Ma Q; Meng J; Liu J; Xu H
Int J Nanomedicine; 2019; 14():5581-5594. PubMed ID: 31413564
[TBL] [Abstract][Full Text] [Related]
6. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
7. Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathway.
Hai Y; Wang X; Song P; Li JY; Zhao LH; Xie F; Tan XM; Xie QJ; Yu L; Li Y; Wu ZR; Li HY
Arch Pharm Res; 2019 Aug; 42(8):684-694. PubMed ID: 31214877
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of arsenic trioxide in human K562 and K562/ADM cells by autophagy.
Cheng J; Wei HL; Chen J; Xie B
Toxicol Mech Methods; 2012 Sep; 22(7):512-9. PubMed ID: 22519831
[TBL] [Abstract][Full Text] [Related]
9. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide.
Goussetis DJ; Gounaris E; Wu EJ; Vakana E; Sharma B; Bogyo M; Altman JK; Platanias LC
Blood; 2012 Oct; 120(17):3555-62. PubMed ID: 22898604
[TBL] [Abstract][Full Text] [Related]
10. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells.
Song P; Hai Y; Wang X; Zhao L; Chen B; Cui P; Xie Q; Yu L; Li Y; Wu Z; Li H
Arch Pharm Res; 2018 Apr; 41(4):467-480. PubMed ID: 29542005
[TBL] [Abstract][Full Text] [Related]
11. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
[TBL] [Abstract][Full Text] [Related]
13. Gambogic acid induces death of K562 cells through autophagy and apoptosis mechanisms.
Chen J; Zhou M; Zhang Q; Xu J; Ouyang J
Leuk Lymphoma; 2015; 56(10):2953-8. PubMed ID: 25699654
[TBL] [Abstract][Full Text] [Related]
14. High expression of bcl-x(L) in K562 cells and its role in the low sensitivity of K562 to realgar-induced apoptosis.
Zhang J; Wang JC; Han YH; Wang LF; Ji SP; Liu SX; Liu XP; Yao LB
Acta Haematol; 2005; 113(4):247-54. PubMed ID: 15983431
[TBL] [Abstract][Full Text] [Related]
15. Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS.
Song P; Chen P; Wang D; Wu Z; Gao Q; Wang A; Zhu R; Wang Y; Wang X; Zhao L; Duan Z; Zhu S; Cui P; Li Y; Li H
Int J Oncol; 2017 Feb; 50(2):660-670. PubMed ID: 28035418
[TBL] [Abstract][Full Text] [Related]
16. [Apoptosis effects of drug sensitivity leukemia cells induced by nano-realgar].
Wang YS; Zhou ST; Wei HL
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(13):2202-5. PubMed ID: 24079254
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL/p62/SQSTM1: a cannibal embrace.
Auberger P
Blood; 2012 Oct; 120(17):3389-90. PubMed ID: 23100300
[TBL] [Abstract][Full Text] [Related]
18. [The mechanism of arsenic trioxide-inducing apoptosis of K562 cells].
Zhang XH; Zhang R; Zhu ZL; Wang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Oct; 12(5):558-62. PubMed ID: 15498110
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic effect of As2S2 on K562 cells and its mechanism.
Li JE; Wu WL; Wang ZY; Sun GL
Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on the molecular mechanism of K562 cell apoptosis induced by As2S2].
Li JE; Sun GL; Wu YL; Wu WL
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):220-4. PubMed ID: 12839680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
